A Prognostic mRNA Expression Signature of Four 16q24.3 Genes in Radio(chemo)therapy-Treated Head and Neck Squamous Cell Carcinoma (HNSCC)

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12388
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Development and Validation of a Gene Signature for Patients With Head and Neck Squamous Cell Carcinomas Treated by Postoperative Radio(chemo)therapy

Clinical Cancer Research
Cancer ResearchOncology
2018English

Retrospective Investigation of the Prognostic Value of the Β1 Integrin Expression in Patients With Head and Neck Squamous Cell Carcinoma Receiving Primary Radio(chemo)therapy

PLoS ONE
Multidisciplinary
2018English

Expression of P53 and Prognosis in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

International Journal of Cancer and Clinical Research
2019English

Radiosensitization of Head and Neck Squamous Cell Carcinoma (HNSCC) by a Podophyllotoxin

English

A Six-mRNA Signature Model for the Prognosis of Head and Neck Squamous Cell Carcinoma

Oncotarget
Oncology
2017English

A Six-mRNA Prognostic Model to Predict Survival in Head and Neck Squamous Cell Carcinoma

Cancer Management and Research
Oncology
2018English

Expression of a Novel mRNA in Human Head and Neck Squamous Cell Carcinoma Cells.

Molecular Pathology
1997English

Targeting Phosphoinositide 3-Kinase (PI3K) in Head and Neck Squamous Cell Carcinoma (HNSCC)

Cancers of the Head & Neck
2018English

Pretreatment Oral Hygiene Habits and Survival of Head and Neck Squamous Cell Carcinoma (HNSCC) Patients

BMC Oral Health
Dentistry
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy